Sökning: id:"swepub:oai:DiVA.org:liu-47536" >
Clinical epidemiolo...
Clinical epidemiology of Guillain-Barré syndrome in adults in Sweden 1996-97 : A prospective study
-
- Cheng, Q. (författare)
- Division of Neurology, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden, Division of Neurology, Huddinge University Hospital, S-141 86 Huddinge, Sweden
-
- Jiang, G.-X. (författare)
- Karolinska Institutet
-
- Press, R. (författare)
- Karolinska Institutet
-
visa fler...
-
- Andersson, M. (författare)
- Karolinska Institutet
-
- Ekstedt, B. (författare)
- Department of Neurology, Karolinska Hospital, Stockholm, Sweden
-
- Vrethem, M. (författare)
- Department of Neurology, Örebro Medical Centre Hospital, Sweden
-
Liedholm, L.J. (författare)
-
- Lindsten, H. (författare)
- Department of Neurology, Östersund Hospital, Östersund, Sweden
-
- Brattstrom, L. (författare)
- Brattström, L., Department of Neurology, University Hospital, Umeå, Sweden
-
- Fredrikson, S. (författare)
- Karolinska Institutet
-
- Link, H. (författare)
- Karolinska Institutet
-
- De, Pedro-Cuesta J. (författare)
- De Pedro-Cuesta, J., Division of Neurology, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden, Department of Applied Epidemiology, National Centre for Epidemiology 'Carlos III', Institute of Health, Madrid, Spain
-
visa färre...
-
(creator_code:org_t)
- Wiley, 2000
- 2000
- Engelska.
-
Ingår i: European Journal of Neurology. - : Wiley. - 1351-5101 .- 1468-1331. ; 7:6, s. 685-692
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- We described clinical manifestations, outcomes, prognostic indicators and clinico-epidemiological subgroups for 53 adult patients with Guillain-Barré syndrome (GBS) in Sweden during the period 1996-97. These patients were identified from a population of 2.8 million inhabitants and prospectively followed up for one year by a network of neurologists. An additional 10 cases, of whom five were adults who had not been prospectively followed up, were not included in the analyses. At 6 months after onset 80% of the patients could walk without aid, while at 1 year 46% were fully recovered, 42% had mild residual signs or symptoms, 4% had moderate and 6% severe disabilities, and 2% had died. Intravenous human immunoglobulin or plasmapheresis were used in 72% of the patients. The sum of the Medical Research Council (MRC) score at nadir was found as the only significant predictor for residual signs at 1 year in a multivariate model. Three subgroups, with different clinico-epidemiological characteristics, were identified by using cluster analysis. In conclusion, GBS in Sweden is frequently preceded by a respiratory infection, is often treated with immunomodulatory therapies, and exhibits a high recovery rate and a low fatality rate.
Nyckelord
- NATURAL SCIENCES
- NATURVETENSKAP
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Cheng, Q.
-
Jiang, G.-X.
-
Press, R.
-
Andersson, M.
-
Ekstedt, B.
-
Vrethem, M.
-
visa fler...
-
Liedholm, L.J.
-
Lindsten, H.
-
Brattstrom, L.
-
Fredrikson, S.
-
Link, H.
-
De, Pedro-Cuesta ...
-
visa färre...
- Artiklar i publikationen
-
European Journal ...
- Av lärosätet
-
Linköpings universitet
-
Karolinska Institutet